Nucleic Acid Extraction Kit for Fecal Samples, Preparation Method and Extraction Method

By using a kit composed of protease K and buffer, combined with magnetic bead technology, the complexity of nucleic acid extraction in fecal samples is solved, efficient and simple high-purity nucleic acid extraction and long-term preservation are achieved, and the effect of PCR detection is improved.

CN114107289BActive Publication Date: 2025-07-15JIANGSU COWIN BIOTECH CO LTD +2

Patent Information

Application Number
CN202111584848.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-22
Publication Date
2025-07-15
Estimated Expiration
2041-12-22

AI Technical Summary

Technical Problem

The fecal samples have complex components and contain a large number of PCR inhibitors, which leads to low nucleic acid extraction concentration and quality, easy to degrade, short storage time, and affects subsequent detection effects.

Method used

The kit consisting of protease K, primary lysis buffer, lysis binding buffer, magnetic bead suspension, rinse solution and elution buffer is used to efficiently extract high-purity nucleic acids through the lysis, adsorption, rinse and elution steps to avoid the presence of nucleases and PCR inhibitors.

Benefits of technology

It realizes efficient and simple nucleic acid extraction, obtains high purity and high yield nucleic acids, which are suitable for automation equipment, extends the storage time of nucleic acids and improves the sensitivity of subsequent PCR detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114107289B_ABST
    Figure CN114107289B_ABST
Patent Text Reader

Abstract

The present invention provides a nucleic acid extraction kit, a preparation method and an extraction method for fecal samples, which relates to the field of biotechnology. The kit includes: proteinase K, primary lysis buffer and lysis-binding buffer; the concentration range of proteinase K is 10-30 mg / mL; the primary lysis buffer contains: 50-200 mM Tris-HCl with pH 6.0-8.5, 0.5-30% (w / v) SDS, 1-10 mM EDTA with pH 8.0-9.0; the lysis-binding buffer contains: 50-200 mM Tris-HCl, 1-15 M guanidine hydrochloride, 1-10 mM EDTA, 0.1-5% Triton X-100, 0.1-5% Tween-20, with pH 7.0-8.0. The DNA nucleic acid extracted and purified by the kit has a high yield and good purity, and solves the problem of short storage time of the DNA extracted from fecal samples.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of molecular biology, and in particular to a nucleic acid extraction kit for stool samples, a preparation method and an extraction method. Background Art

[0002] Fecal samples or intestinal content samples are important sample sources for intestinal disease research and intestinal clinical testing. Feces or intestinal contents contain a large number of host digestive tract exfoliated cells and free nucleic acids, which often contain cancer signals. The detection of exfoliated cells and free nucleic acids in feces or intestinal contents is non-invasive, painless, and has high specificity. It is often used in the initial screening of digestive tract diseases such as colorectal cancer, which can better achieve the purpose of "early detection, early diagnosis, and early treatment". It is the most effective and cost-effective method to reduce the incidence and mortality of intestinal cancer (colorectal cancer). The main samples for intestinal microbial research are also fecal samples or intestinal content samples, which can reflect the symbiotic state of microorganisms in the human intestine.

[0003] However, stool samples are complex in composition, contain a lot of impurities such as food residues, and contain a large amount of proteases, nucleases, and various PCR inhibitors such as bile salts, bilirubin, humus, and pigments. Most conventional nucleic acid separation and purification technologies cannot effectively remove inhibitors and other substances. Therefore, the nucleic acid concentration and quality of stool samples separated and purified by conventional methods are low, easy to degrade, and have a short shelf life. In addition, detection inhibitors are often separated and concentrated along with DNA separation and purification, which has an adverse effect on subsequent nucleic acid detection and often causes the failure of PCR amplification experiments.

[0004] In view of this, the present invention is proposed. Summary of the Invention

[0005] The present invention aims to provide a nucleic acid extraction kit, preparation method, and extraction method for stool samples. The kit is easy to operate and can be used in conjunction with automatic nucleic acid extraction equipment. The extracted and purified DNA has a high yield and high purity, is free of nucleases and PCR inhibitors, and effectively solves the problem of short storage time of DNA extracted from stool samples, thereby facilitating the storage of DNA and subsequent PCR detection.

[0006] In order to achieve the above-mentioned purpose of the present invention, the following technical solutions are adopted:

[0007] In a first aspect, the present invention provides a stool sample DNA nucleic acid extraction kit, which mainly includes the following components: proteinase K, initial lysis buffer, lysis binding buffer, magnetic bead suspension, first rinse solution, second rinse solution and elution buffer.

[0008] [Proteinase K]

[0009] Proteinase K is a serine protease with a broad cleavage activity. It cleaves the carboxyl-terminal peptide bonds of aliphatic and aromatic amino acids, degrading proteins into small peptides or amino acids, allowing for the complete separation of DNA molecules. Proteinase K can degrade proteins and inactivate nucleases such as DNase and RNase. Proteinase K is active over a wide pH range of 4-12.5 and a temperature range of 37-60°C. It is active in salt concentrations of 3M guanidine hydrochloride or 4M urea, and is also active in the presence of Tween 20 (5%) and SDS (1%) detergents.

[0010] The concentration of proteinase K ranges from 10-30 mg / mL, for example, 10, 15, 20, 25, 30 mg / mL.

[0011] In a preferred embodiment, the concentration of Proteinase K is in the range of 20 mg / mL.

[0012] [Primary lysis buffer]

[0013] The primary lysis buffer includes: ion buffer material 50-200mM (for example 50, 100, 150, 200mM) Tris-HCl (pH6.0-8.5), surfactant 0.5%-30% (for example 0.5, 1, 2, 5, 10, 15, 20, 25, 30%) (w / v) SDS, metal ion chelator 1-10mM (for example 1, 2, 3, 4, 5, 6, 7, 8, 9, 10mM) EDTA, and the balance water. The pH of the primary lysis buffer is 8.0-9.0.

[0014] In a preferred embodiment, the components in the primary lysis buffer are as follows: 100 mM Tris-HCl, 10% (w / v) SDS, 8 mM EDTA, and the pH of the primary lysis buffer is 8.5.

[0015] The primary lysis buffer provided by the present invention can ensure that all cells in the sample are rapidly lysed, nucleic acids are separated from nucleic acid-binding proteins, and nucleic acids are released when lysing a stool sample.

[0016] The specific principles are as follows:

[0017] Tris-HCl: It can provide a stable buffer environment of pH 6.0-9.0, maintain the charged state of nucleic acid phosphate groups and magnetic beads, facilitate the maintenance of hydrogen bonds, protect DNA bases, and not easily destroy their integrity or cause breakage.

[0018] Sodium dodecyl sulfate (SDS): An anionic detergent that can destroy the electrostatic attraction or coordination bonds between proteins and nucleic acids under high temperature (55-65°C), allowing chromosome resolution, protein denaturation, the formation of SDS / protein / polysaccharide complexes, and the release of nucleic acids. It is simple and gentle to operate and can extract high molecular weight DNA.

[0019] Ethylenediaminetetraacetic acid (EDTA): EDTA is a divalent ion chelator that can chelate Mg 2+ , Ca 2+ or Mn 2+ Divalent cations such as dapoxets can inhibit the activity of metal-dependent enzymes such as DNase and RNase, and can inhibit the degradation of nucleic acids released after cleavage by nucleases, thereby reducing the loss of free nucleic acids during the extraction process.

[0020] [Lysis-binding buffer]

[0021] Lysis-binding buffer, including: 50-200mM (e.g., 50, 100, 150, 200mM) Tris-HCl, 1-15M (e.g., 1, 2, 5, 8, 10, 12, 15M) guanidine hydrochloride, 1-10mM (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10mM) EDTA, 0.1-5% (e.g., 0.1, 1, 2, 3, 4, 5%) TritonX-100, 0.1-5% (e.g., 0.1, 1, 2, 3, 4, 5%) Tween-20, pH 7-8.

[0022] In a preferred embodiment, the components in the lysis-binding buffer are: 50 mM Tris-HCl (pH 6.0-8.0), 10 M guanidine hydrochloride, 4 mM EDTA, 1% Triton X-100, 3% Tween-20, and its pH is 7.5.

[0023] The specific principles are as follows:

[0024] Guanidine hydrochloride: As a protein denaturant, it can dissolve proteins, leading to the destruction of cell structure and the secondary structure of nucleoproteins, and dissociation from nucleic acids. In addition, guanidine hydrochloride is a strong inhibitor of nucleases, and works synergistically with EDTA to prevent nucleic acids from being degraded by nucleases during the extraction process.

[0025] Triton X-100 (polyethylene glycol octylphenyl ether) is a relatively mild nonionic detergent that dissolves lipids in cell membranes. When using Triton X-100 to lyse cells, 0.1% Triton X-100 is sufficient, but 0.5% is also acceptable. Proteinase K remains active in solutions containing 1% Triton X-100.

[0026] Tween-20 is a non-ionic surfactant, widely used as an emulsifier and solubilizer for oily substances. It emulsifies proteins in biological experiments and works synergistically with the same type of Triton X-100. It does not destroy the structure of the protein, but can reduce the original interaction between proteins.

[0027] Before adding the magnetic bead suspension for nucleic acid adsorption, a certain volume of isopropanol needs to be added to the sample-adsorption binding mixture. The main function of isopropanol is to precipitate nucleic acids.

[0028] [Magnetic bead suspension]

[0029] Magnetic bead suspension: superparamagnetic microspheres with a volume fraction of 70-80%, the particle size of the superparamagnetic microspheres is between 10 and 50 nm, and the pH value of the magnetic bead suspension is 5.0-6.0.

[0030] In a preferred embodiment, the magnetic bead suspension comprises 70% by volume of magnetic beads (particle size between 10 and 50 nm), 30% nuclease-free water, and a pH of 5.4. It is important to note that the magnetic bead suspension should be stored at 4-8°C and should not be frozen.

[0031] [First rinse]

[0032] The first rinsing solution includes: 10-100mM (e.g., 10, 20, 30, 40, 50, 60, 70, 80, 90, 100mM) Tris-HCl (pH 6.0-8.0), 10-100mM (e.g., 10, 20, 30, 40, 50, 60, 70, 80, 90, 100mM) sodium chloride, 1-10mM (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10mM) EDTA buffer, and 50-80% (e.g., 50, 55, 60, 65, 70, 75, 80%) ethanol.

[0033] In a preferred embodiment, the first rinse solution comprises: 50 mM Tris-HCl, 100 mM sodium chloride, 4 mM EDTA, pH 8.0, and 70% ethanol.

[0034] [Second rinse]

[0035] The second rinse solution includes: 10-100mM (e.g., 10, 20, 30, 40, 50, 60, 70, 80, 90, 100mM) Tris-HCl, 1-5mM (e.g., 1, 2, 3, 4, 5mM) EDTA, pH 6.0-8.0, 50-80% (e.g., 50, 55, 60, 65, 70, 75, 80%) ethanol.

[0036] In a preferred embodiment, the second rinse solution comprises 50 mM Tris-HCl, 4 mM EDTA, pH 8.0, and 80% ethanol, and is used to wash away residual salt ions and guanidine salts to avoid adverse effects on subsequent molecular biology experiments after nucleic acid extraction.

[0037] [Elution buffer]

[0038] The elution buffer comprises: 5-20 mM (e.g., 5, 8, 10, 12, 15, 18, 20 mM) Tris-HCl (pH 6.0-8.0), 1-5 mM (e.g., 1, 2, 3, 4, 5 mM) EDTA, and the balance water.

[0039] In a preferred embodiment, the composition of the elution buffer is: 10 mM Tris-HCl, 2 mM EDTA, pH 8.0.

[0040] The stool sample DNA nucleic acid extraction kit of the present invention can quickly and efficiently lyse various cells in stool samples through various reagents, fully releasing nucleic acids, so that high-purity and high-yield nucleic acids can be obtained from a small amount of stool sample, meeting the requirements for subsequent nucleic acid testing. In addition, the extracted nucleic acids are free of nucleases and PCR detection inhibitors, and the DNA has a long storage life. It is highly sensitive for subsequent molecular detection such as nucleic acid PCR amplification, which facilitates the storage and detection of nucleic acids in stool samples. It is simple to operate, efficient, and can be used with automated extraction equipment.

[0041] In a second aspect, the present invention provides a method for preparing the above-mentioned nucleic acid extraction kit, comprising the following steps:

[0042] (a) obtaining proteinase K;

[0043] (b) Preparation of primary lysis buffer: adding the metal ion chelating agent, the buffer substance of the buffer solution and the surfactant to deionized water, dissolving and mixing the components to obtain a mixture, and adjusting the pH of the mixture to 8.0-9.0.

[0044] (c) Preparation of lysis-binding buffer: adding the guanidine hydrochloride, Tris-HCl, EDTA, Triton X-100 and Tween-20 to deionized water, and dissolving and mixing the components to obtain a mixture, and adjusting the pH of the mixture to 7-8.

[0045] (d) Obtaining a magnetic bead suspension: Add superparamagnetic microspheres to nuclease-free water to form a suspension.

[0046] (e) Preparation of the first rinse solution: Add the Tris-HCl, sodium chloride, and EDTA to deionized water, dissolve and mix the components to obtain a mixture, and adjust the pH of the mixture to 7-8. Before use, add anhydrous ethanol to a final ethanol concentration of 50-80%.

[0047] (f) Preparation of the second rinse solution: Add the Tris-HCl and EDTA to deionized water, dissolve and mix the components to obtain a mixture, and adjust the pH of the mixture to 6.0-8.0.

[0048] (g) Preparation of elution buffer: Add the Tris-HCl and EDTA to deionized water, dissolve and mix the components to obtain a mixture, and adjust the pH of the mixture to 8.0.

[0049] In a third aspect, a method for extracting nucleic acid from stool samples is provided.

[0050] In general, the extraction method of this kit can be roughly divided into four steps. The first step is to use a lysis buffer to lyse the cells and promote the separation and release of nucleic acids and nuclear proteins; the second step is to specifically adsorb the released nucleic acids on magnetic beads, and the magnetic beads only have a strong affinity and adsorption capacity for nucleic acids, and have no affinity and adsorption capacity for other biochemical components such as proteins, polysaccharides, and lipids; the third step is rinsing to wash away non-specifically bound components; the fourth step is to elute the nucleic acids adsorbed on the magnetic beads to obtain purified nucleic acids.

[0051] Preferably, the mass / volume ratio of the stool sample or stool preservation solution sample to proteinase K is 5:1-20:1. In some preferred embodiments, the volume ratio of the sample to be processed to proteinase K is 10:1.

[0052] The stool sample nucleic acid extraction kit according to the first aspect of the present invention is used to extract total DNA from a 0.25-2 g stool sample or a 200-400 μl stool preservation solution sample, and the specific steps include:

[0053] 1. Sample lysis: Take 0.25-2g fresh or frozen stool sample, or 200-400μl stool preservation solution sample, place it in a clean EP tube (self-prepared), add 200-800μl primary lysis buffer, vortex continuously for 1 minute or until the stool sample is fully homogenized, place the sample on a constant temperature mixer, 70℃, 600rpm, lysis incubation for 3-5 minutes, then 80℃, 600rpm, incubate for 5-10 minutes, centrifuge the sample at 8000-12000rpm for 1-5 minutes to precipitate fecal impurities, aspirate 200-500μl supernatant into a new EP tube, add 10-25μl proteinase K, add 200-400μl lysis and binding buffer, vortex mix, place on a constant temperature mixer, 80℃, 600rpm, incubate for 20 minutes.

[0054] 2. Adsorption and binding: Add 200-400 μl of isopropanol to the above sample, add 10-25 μl of magnetic bead suspension, invert to mix, place on a constant temperature mixer, room temperature, 600 rpm, incubate for 5-10 minutes, place the EP tube on the magnetic rack, let it stand for 3-5 minutes until all the magnetic beads are adsorbed, and discard all the liquid.

[0055] 3. Rinse: Add 500-750μl of the first rinse solution to the above EP tube, blow and mix with a gun, place it on a magnetic rack, let it stand for 3-5 minutes until all the magnetic beads are adsorbed, discard all the liquid, and repeat the rinsing step with the first rinse solution once; then add 500-750μl of the second rinse solution, blow and mix with a gun, place it on a magnetic rack, let it stand for 3-5 minutes until all the magnetic beads are adsorbed, discard all the liquid, and repeat the rinsing step with the second rinse solution once.

[0056] 4. Elution: Open the above EP tube and let it stand at room temperature for 3-5 minutes. Dry the magnetic beads to remove residual rinsing solution to avoid affecting downstream experiments. Add 70μl elution buffer, mix well by pipetting, and incubate at 65℃ on a constant temperature mixer for 5-10 minutes. Finally, place the EP tube on a magnetic rack and let it stand for 3-5 minutes until all the magnetic beads are adsorbed. Pipette all the liquid into a new EP tube, which is the fecal sample DNA nucleic acid. Store at -20℃ for later use.

[0057] The nucleic acid extraction kit, preparation method, and extraction method for stool samples provided by the present invention have at least the following beneficial effects:

[0058] (1) Simple and efficient, suitable for automated extraction equipment: The kit can be used in conjunction with an automatic nucleic acid extractor. It is easy to operate and can quickly and efficiently lyse various cell types in fecal samples, fully releasing nucleic acids. This allows nucleic acids of high purity and yield to be obtained using a small amount of fecal samples, meeting the requirements for subsequent nucleic acid testing.

[0059] (2) The extracted nucleic acid is of high purity and does not contain detection inhibitors: The extracted nucleic acid does not contain nucleases and detection inhibitors, the DNA has a long preservation time, and the sensitivity of subsequent molecular detection such as nucleic acid PCR amplification is high, which is conducive to the preservation and detection of nucleic acid in fecal samples.

[0060] (3) Low cost: All components of the kit are independently developed and mass-produced, with low cost, which can meet the research and application needs in multiple fields of molecular biology and has broad application prospects and market promotion value. BRIEF DESCRIPTION OF THE DRAWINGS

[0061] In order to more clearly illustrate the specific embodiments of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for use in the specific embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0062] Figure 1 This is the result of qPCR detection of the preservation effect of DNA nucleic acid in stool samples after extraction. DETAILED DESCRIPTION

[0063] The following will clearly and completely describe the technical solutions of the present invention in conjunction with the embodiments. Obviously, the embodiments described are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts are within the scope of protection of the present invention.

[0064] The present invention is further described below by way of examples. Unless otherwise specified, the materials in the examples were prepared according to existing methods or directly purchased from the market.

[0065] Example 1

[0066] This embodiment provides a stool sample DNA nucleic acid extraction kit and preparation method. The kit includes proteinase K, initial lysis buffer, lysis-adsorption binding buffer, magnetic bead suspension, first rinse solution, second rinse solution, and elution buffer.

[0067] In this embodiment, the reagent components of the kit are as follows:

[0068] Proteinase K was 20 mg / mL;

[0069] The primary lysis buffer contained: 100 mM Tris-HCl, 10% (w / v) SDS, 8 mM EDTA, and the pH of the lysis buffer was 8.5.

[0070] The lysis-adsorption binding buffer contains: 50 mM Tris-HCl (pH 6.0-8.0), 10 M guanidine hydrochloride, 4 mM EDTA, 1% Triton X-100, 3% Tween-20, and its pH is 7.5;

[0071] The magnetic bead suspension contains: 70% by volume of magnetic beads (particle size is between 10 and 50 nm), 30% nuclease-free water, and the pH of the magnetic bead suspension is 4.5;

[0072] The first rinse solution contained: 50 mM Tris-HCl, 100 mM sodium chloride, 4 mM EDTA, pH 8.0, 70% ethanol;

[0073] The second rinse solution contained 50 mM Tris-HCl, 4 mM EDTA, pH 8.0, and 80% ethanol;

[0074] The elution buffer contained 10 mM Tris-HCl, 2 mM EDTA, pH 8.0.

[0075] Example 2 DNA extraction method of stool samples (manual extraction)

[0076] The stool extraction kit reagents prepared in Example 1 were used to extract DNA nucleic acid from stool samples.

[0077] The specific steps for manual extraction are as follows:

[0078] 1. Sample Lysis

[0079] Fresh or frozen stool sample: Take 0.2-0.3g fresh or frozen stool sample into a 2ml clean centrifuge tube, add 600μl primary lysis buffer, and vortex continuously for 1 minute until the stool sample is fully homogenized.

[0080] Samples preserved in fecal preservation solution: Take 300 μl of fecal preservation solution sample, place it in a 2 mL clean centrifuge tube, add 300 μl of primary lysis buffer, and vortex continuously for 1 minute until the fecal sample is fully homogenized.

[0081] The fully homogenized sample was placed on a thermomixer at 70°C, 600 rpm for 5 minutes of lysis incubation, followed by incubation at 80°C, 600 rpm for 10 minutes. The sample was centrifuged at 12,000 rpm for 1 minute to precipitate fecal impurities. 400 μl of the supernatant was transferred to a new centrifuge tube, 20 μl of proteinase K was added, 300 μl of lysis-binding buffer was added, vortexed to mix, and placed on a thermomixer at 80°C, 600 rpm for 20 minutes of incubation.

[0082] 2. Adsorption and binding

[0083] Add 300 μl of isopropanol to the above sample, add 20 μl of magnetic bead suspension, invert to mix, place on a constant temperature mixer, incubate at room temperature, 600 rpm, incubate for 8 minutes, place the centrifuge tube on a magnetic rack, let it stand for 5 minutes until all the magnetic beads are adsorbed, and discard all the liquid.

[0084] 3. Rinse

[0085] Add 750 μl of the first rinse solution to the above centrifuge tube, mix it with a gun, place it on a magnetic rack, let it stand for 5 minutes until all the magnetic beads are adsorbed, discard all the liquid, and repeat the rinsing step with the first rinse solution once; then add 750 μl of the second rinse solution, mix it with a gun, place it on a magnetic rack, let it stand for 5 minutes until all the magnetic beads are adsorbed, discard all the liquid, and repeat the rinsing step with the second rinse solution once.

[0086] 4. Elution

[0087] Open the above centrifuge tube and let it stand at room temperature for 3-5 minutes. Dry the magnetic beads to remove residual rinsing solution to avoid affecting downstream experiments. Add 70μl elution buffer, mix well by pipetting, and incubate at 65℃ on a constant temperature mixer for 10 minutes. Finally, place the centrifuge tube on a magnetic rack and let it stand for 3-5 minutes until all the magnetic beads are adsorbed. Pipette all the liquid into a new centrifuge tube, which is the fecal sample DNA nucleic acid, and store it at -20℃ for later use.

[0088] Example 3 Optimization of the automatic extraction procedure of the stool DNA extraction kit

[0089] Sample: Fresh stool sample

[0090] Reagent: Extraction reagent prepared according to Example 1

[0091] Instrument: CWE2100 automatic nucleic acid extraction instrument (Kangwei Century)

[0092] The specific operations for matching the CWE2100 instrument are as follows:

[0093] 1. Sample Pretreatment

[0094] Fresh or frozen stool sample: Take 0.2-0.3g fresh or frozen stool sample into a 2ml clean centrifuge tube, add 600μl primary lysis buffer, and vortex continuously for 1 minute until the stool sample is fully homogenized.

[0095] Samples preserved in fecal preservation solution: Take 300 μl of fecal preservation solution sample, place it in a 2 mL clean centrifuge tube, add 300 μl of primary lysis buffer, and vortex continuously for 1 minute until the fecal sample is fully homogenized.

[0096] The fully homogenized sample was placed on a thermomixer at 70°C, 600 rpm for 5 minutes, followed by incubation at 80°C, 600 rpm for 10 minutes. The sample was centrifuged at 12,000 rpm for 1 minute to precipitate fecal impurities, and 400 μl of the supernatant was collected for later use.

[0097] 2. Adsorption, rinsing, and elution

[0098] Add reagents to the 96-well plate according to the following table (remember to add reagents to 1 & 7 volumes in the order shown in the table):

[0099]

[0100] Place the deep-well plate and magnetic sleeve with reagents added in the corresponding positions of the nucleic acid extraction instrument, and run different automated extraction programs as shown in Schemes 1 to 6 in the table below.

[0101]

[0102]

[0103]

[0104]

[0105]

[0106]

[0107]

[0108] After approximately 20 minutes of running in Protocol 1, the program was paused. 300 μl of isopropanol and 20 μl of magnetic bead suspension were added to each sample in columns 1 and 7, and the program was continued. The program concluded after approximately 35 minutes. After the program concluded, the 96-well plate and magnetic sleeve were removed, and the eluate (extracted nucleic acid) in columns 6 and 12 of the deep-well plate was transferred to a clean centrifuge tube and stored at low temperature until further use.

[0109] Detection of the concentration and purity of extracted DNA nucleic acid and fluorescence quantitative PCR amplification test

[0110] The extracted DNA was quantitatively measured using the dsDNA HS Assay Kit for Qubit (Kangwei Century, Cat. No. CW2838), and the purity of the nucleic acid samples was detected using Nanodrop. 5 μl of each sample was used as a template for fluorescence quantitative qPCR detection of human internal reference genes and bacterial 16S genes.

[0111] The extracted DNA samples were subjected to fluorescent quantitative PCR detection using Kangwei Century qPCR detection reagent (Cat. No. CW0957). The primers used were human internal reference gene β-actin primers (primer sequence information: βactin-F: GCGCCGTTCCGAAAGTT (SEQ ID NO. 1), βactin-R: CGGCGGATCGGCAAA (SEQ ID NO. 2) and bacterial 16S internal reference gene primers 341F / 517R (341F: 5'-CCTACGGGAGGCAGCAG-3' (SEQ ID NO. 3); 517R: 5'-ATTACCGCGGCTGCTGG-3' (SEQ ID NO. 4)). DNA nucleic acid extracted from fecal preservation fluid without adding fecal sample was used as a negative control. Specific procedures are described in the manufacturer's instructions. The reaction system used a 15μl PCR reaction system (including: 10μl UltraSYBR Mixture, 0.4μl βactin-F / 341F (10 μM), 0.4 μl βactin-R / 517R (10 μM), 4.2 μl nuclease-free water) + 5 μl extracted DNA sample template. Human reference gene actin and bacterial 16S gene nucleic acid detection were performed on an ABI7500 (Thermofisher, USA) fluorescence quantitative PCR instrument. Reaction conditions were as follows: 95°C for 5 min → 95°C for 10 s, 60°C for 30 s (40 cycles), SYBR channel. All assays were repeated three times, and the average cycling threshold (Ct) was calculated. The results of the extracted nucleic acid test are shown in Table 1. Automated extraction protocol 3, with a short run time, resulted in relatively good extracted nucleic acid concentration, purity, and subsequent PCR test results.

[0112] Table 1. Comparison of the effects of different automated extraction procedures on DNA extraction

[0113]

[0114] Example 4 Optimization of sample pretreatment conditions of stool DNA extraction kit

[0115] Sample: Stool fluid sample

[0116] Reagent: Extraction reagent prepared according to Example 1

[0117] Instrument: CWE2100 automatic nucleic acid extraction instrument (Kangwei Century)

[0118] The specific operations for matching the CWE2100 instrument are as follows:

[0119] 1. Sample Pretreatment

[0120] Take 300 μl of fecal preservation solution and place it in a clean 2 mL centrifuge tube. Add 300 μl of primary lysis buffer and vortex continuously for 1 minute until the fecal sample is fully homogenized. Place the fully homogenized sample on a thermomixer at 600 rpm and perform primary lysis on the fecal sample according to the conditions of Scheme 1 to Scheme 5 in the table below:

[0121] Solution 1 70℃ 5min, 80℃ 10min Option 2 70℃ 10min Option 3 70℃ 5min Option 4 80℃ 10min Option 5 80℃ 5min

[0122] After sample processing, the sample was centrifuged at 12000 rpm for 1 minute to precipitate fecal impurities, and 400 μl of the supernatant was aspirated for later use.

[0123] 2. Lysis, adsorption, rinsing, and elution

[0124] According to the extraction scheme 3 in Example 3, reagents were added to the 96-deep-well plate, the deep-well plate with added reagents and the magnetic sleeve were placed in the corresponding positions of the nucleic acid extraction instrument, and the instrument was operated according to the extraction program scheme 3 in Example 3 to perform automated extraction.

[0125] Fluorescence quantitative PCR amplification detection of extracted DNA nucleic acid:

[0126] After the DNA was extracted, 5 μl of each sample was used as a template for fluorescence quantitative PCR detection of human internal reference genes and bacterial 16S genes. The extracted DNA nucleic acid samples were subjected to fluorescence quantitative PCR detection using Kangwei Century qPCR detection reagent (Cat. No. CW0957). The primers used were human internal reference gene β-actin primers and bacterial 16S internal reference gene primers. For specific operations, refer to the instructions. The reaction system used a 15 μl PCR reaction system (including: 10 μl UltraSYBR Mixture, 0.4 μl βactin-F / 341F (10 μM), 0.4 μl βactin-R / 517R (10 μM), 4.2 μl nuclease-free water) + 5 μl extracted DNA sample template. Detection was performed on an ABI7500 (Thermofisher, USA) fluorescence quantitative PCR instrument. The reaction conditions were as follows: 95°C 5 min → 95°C 10 s, 60°C 30 s (40 cycles), SYBR channel. All tests were repeated three times, and the average Ct value was calculated.

[0127] The results of nucleic acid extraction are shown in Table 2. Sample pretreatment solution 3: After treatment at 70°C for 5 minutes, automated extraction was performed, and human genome and bacterial genome PCR detection was performed after extraction. The overall effect was good.

[0128] Table 2. Fluorescence quantitative PCR detection of nucleic acid DNA extracted by different pre-treatment schemes

[0129]

[0130] Example 5 Testing the extraction effects of different magnetic beads

[0131] Experimental materials: fresh fecal preservation fluid sample; fecal sample extraction reagent prepared in Example 1, wherein the magnetic beads were selected from domestic magnetic beads 1 (Yingruicheng MSi100-DNA-0507), domestic magnetic beads 2 (Jinent GNT-108) and imported magnetic beads (Promega, MD1441).

[0132] Experimental Method: Take 9 equal portions (300 μl each) of fresh fecal preservation fluid sample and place them in clean centrifuge tubes. Add 300 μl of primary lysis buffer to each tube and vortex continuously for 1 minute until the fecal sample is fully homogenized. Place the fully homogenized sample on a thermomixer at 70°C, 600 rpm, and incubate for 5 minutes. After that, centrifuge the sample at 12,000 rpm for 1 minute to precipitate fecal impurities. Aspirate 400 μl of the supernatant and run the instrument according to Extraction Protocol 3 for the CWE2100 instrument in Example 3 for automated extraction.

[0133] The 9 samples were divided into three groups and subjected to three extraction treatments: (Domestic magnetic bead group 1) 3 samples were extracted using domestic magnetic beads from Yingruicheng Biochemical Technology (item number MSi100-DNA-0507); (Domestic magnetic bead group 2) 3 fecal samples were extracted using domestic magnetic beads from Genet Bio (item number GNT-108); (Imported magnetic bead group) 3 fecal samples were extracted using Promega magnetic beads (item number: MD1441).

[0134] The extracted DNA was tested for nucleic acid sample concentration and purity using Nanodrop. The results are shown in Table 3. The extraction effect of the domestic magnetic bead group was basically the same, while the nucleic acid concentration extracted by the imported magnetic bead extraction group was significantly higher and the purity was better.

[0135] Table 3. Comparison of extraction effects of different magnetic beads

[0136]

[0137] Example 6: Test of the reaction system of the stool sample extraction kit

[0138] Experimental materials: Fresh fecal samples provided by 3 volunteers;

[0139] Experimental group reagents: Some stool sample extraction reagents prepared in Example 1 (using Promega magnetic beads);

[0140] Comparative group reagent: stool sample extraction reagent prepared in Example 1 (using Promega magnetic beads);

[0141] Experimental Methods: Fresh stool samples provided by three volunteers were stored in stool DNA preservation solution (Carewell, Cat. No. CW2654). After mixing, three aliquots (300 μl each) of each sample were dispensed into clean centrifuge tubes and subjected to three extraction treatments:

[0142] (A) Experimental Group Reagent 1: Three samples were taken and initially processed according to Example 3. The reagents required for extraction are described in Table 4. The automated extraction procedure was performed according to Scheme 3 in Example 3.

[0143] Table 4 Experimental group reagent 1

[0144]

[0145] (B) Experimental Group Reagent 2: Three samples were taken and initially processed according to Example 3. The reagents required for extraction are described in Table 5. The extraction procedure was automated according to Scheme 3 in Example 3.

[0146] Table 5 Experimental group reagent 2

[0147]

[0148] (C) Comparative group reagents: Three samples were taken and initially processed according to Example 3. The reagents required for extraction were as described in Table 6. The extraction procedure was automated according to Scheme 3 in Example 3.

[0149] Table 6 Comparative group reagents

[0150]

[0151] After extraction, the DNA concentration and purity were tested using a nanodrop. The results are shown in Table 7. Both experimental reagents 1 and 2 showed lower nucleic acid yield and purity than the control reagent, indicating that proteinase K and binding buffer must be used together.

[0152] Table 7

[0153]

[0154] Example 7: Extraction Capacity Test of Stool Sample Extraction Kit

[0155] Experimental materials: Fresh stool samples provided by 5 volunteers, Helicobacter pylori.

[0156] Experimental group reagents: stool sample extraction reagent prepared in Example 1 (using Promega magnetic beads);

[0157] Comparison group reagents: QIAGEN stool sample rapid extraction kit ( Fast DNA StoolMini Kit, Cat No. / ID: 51604).

[0158] Experimental Methods: Fresh stool samples provided by five volunteers were stored in stool DNA preservation solution (Carewell Century, Cat. No. CW2654). Equal volumes of Helicobacter pylori culture were added to each sample and mixed thoroughly. Nine aliquots (300 μl each) were taken from each sample and dispensed into clean centrifuge tubes. Three extraction treatments were performed:

[0159] (A) Experimental group reagents - CWE2100 instrument extraction group: 3 samples were collected, 300 μl of primary lysis buffer was added to each sample, and the stool samples were vortexed continuously for 1 minute until fully homogenized. The fully homogenized samples were placed on a thermomixer at 70°C, 600 rpm, and incubated for 5 minutes. The samples were then centrifuged at 12,000 rpm for 1 minute to precipitate fecal impurities. 400 μl of the supernatant was aspirated and automated extraction was performed using the instrument according to extraction protocol 3 in Example 3.

[0160] (B) Experimental Reagents - Manual Extraction Group: Three samples were collected and 300 μl of primary lysis buffer was added to each sample. The fecal samples were vortexed continuously for 1 minute until fully homogenized. The fully homogenized samples were placed on a thermomixer at 70°C, 600 rpm, and incubated for 5 minutes. The samples were then centrifuged at 12,000 rpm for 1 minute to precipitate fecal impurities. 400 μl of the supernatant was aspirated and DNA was extracted using the manual extraction method for samples stored in fecal preservation solution as described in Example 2.

[0161] (C) Comparative group reagent - manual extraction group: 3 samples (300 μl each) were taken and extracted using QIAGEN's stool sample rapid extraction kit (catalog number 51604) according to the instructions.

[0162] After extraction, the DNA concentration and purity were measured using a nanodrop assay. Three samples were processed in parallel for each experiment, and the experimental data are the mean of the three replicates. The experimental results, shown in Table 8, show that the concentration and purity of the manual and machine extraction groups were essentially equivalent, with both achieving high nucleic acid yields. Subsequent quantitative PCR detection of human and bacterial genome reference genes showed no significant differences between the manual and machine extraction groups, with similar Ct values. In terms of the purity of the extracted nucleic acid, although the QIAGEN fecal extraction method uses a centrifugal column method for extraction, the Abs260 / Abs280 ratio is relatively low, mostly between 1.5 and 1.8, and the Abs260 / Abs230 ratio is less than 1, indicating relatively low purity, which may be due to guanidine salt or protein contamination. However, the fecal nucleic acid extraction reagent and method provided in the experimental group of this example use a magnetic bead adsorption method, and the purity Abs260 / Abs280 ratio is mostly distributed between 1.8 and 2.0, and the Ab260 / Abs230 ratio is between 1.0 and 1.5, indicating relatively high purity, and the PCR detection Ct value is lower, which can better meet the requirements of subsequent nucleic acid detection experiments.

[0163] Table 8. Extraction performance test of stool extraction kit

[0164]

[0165] Extracted nucleic acid storage time detection: The extracted nucleic acid samples were mixed according to different treatment groups, namely three nucleic acid groups A, B, and C. Each group was divided into two equal parts and stored at room temperature for 0 days and 7 days, respectively. 5 μl of each aliquot was used as a template for fluorescence quantitative PCR detection. The extracted DNA nucleic acid samples were subjected to fluorescence quantitative PCR detection using Kangwei Century qPCR detection reagent (Cat. No. CW0957). The primers used were human internal reference gene β-actin primers, with primer sequence information of βactin-F: GCGCCGTTCCGAAAGTT (SEQ ID NO. 1) and βactin-R: CGGCGGATCGGCAAA (SEQ ID NO. 2). The reaction system used a 15 μl PCR reaction system (including: 10 μl UltraSYBR Mixture, 0.4 μl βactin-F (10 μM), 0.4 μl βactin-R (10 μM), 4.2 μl nuclease-free water) + 5 μl extracted DNA sample template. Detection of the human reference gene actin was performed on a CFX96 (BioRad, USA) fluorescence quantitative PCR instrument. Reaction conditions were as follows: 95°C for 5 min → 95°C for 10 s, 60°C for 30 s (45 cycles), using the SYBR channel. All assays were repeated three times, and the average cycling threshold (Ct) was calculated.

[0166] Experimental results: The results are shown in Table 9 and Figure 1 As shown in the figure, compared with the Ct of the control group on day 0, the Ct differences of the nucleic acid samples of the experimental groups A and B and the nucleic acid sample of the control group C after being stored at room temperature for 7 days were mostly insignificant, indicating that the extraction kit provided by the present invention can effectively maintain the stability of DNA nucleic acid, whether it is manual extraction or nucleic acid extraction with an automated extraction instrument, and can ensure effective detection of nucleic acid even after storage for 7 days.

[0167] Table 9. Preservation of DNA nucleic acid in stool samples after qPCR detection

[0168]

[0169] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the above embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention. Sequence Listing <110> Jiangsu Kangwei Century Biotechnology Co., Ltd. Kangwei Medical Testing Laboratory (Taizhou) Co., Ltd. Beijing Jianwei Medical Testing Laboratory Co., Ltd. <120> Nucleic acid extraction kit for fecal samples, preparation method and extraction method <160> 4 <170> SIPOSequenceListing 1.0 <210> 1 <211> 17 <212> DNA <213> Artificial sequence <400> 1 gcgccgttcc gaaagtt 17 <210> 2 <211> 15 <212> DNA <213> Artificial sequence <400> 2 cggcggatcg gcaaa 15 <210> 3 <211> 17 <212> DNA <213> Artificial sequence <400> 3 cctacgggag gcagcag 17 <210> 4 <211> 17 <212> DNA <213> Artificial sequence <400> 4 attaccgcgg ctgctgg 17

Claims

1. A nucleic acid extraction kit for fecal samples, characterized in that, The nucleic acid extraction kit includes: proteinase K, primary lysis buffer, and lysis-binding buffer; The concentration of the proteinase K is 20 mg / mL; The primary lysis buffer contains: 100 mM Tris-HCl, 10% (w / v) SDS, 8 mM EDTA, pH 8.5; The lysis-binding buffer contains: 50 mM Tris-HCl, 10 M guanidine hydrochloride, 4 mM EDTA, 1% Triton X-100, 3% Tween-20, pH 7.5; The nucleic acid extraction kit further includes: magnetic bead suspension, first wash buffer, second wash buffer, and elution buffer; The magnetic bead suspension is: 70% (v / v) superparamagnetic microspheres, 30% (v / v) nuclease-free water, pH 5.4; the superparamagnetic microspheres are the magnetic beads of Promega; The first wash buffer contains: 50 mM Tris-HCl, 100 mM NaCl, 4 mM EDTA, 70% ethanol, pH 8.0; The second wash buffer contains: 50 mM Tris-HCl, 4 mM EDTA, 80% ethanol, pH 8.0; The elution buffer contains: 10 mM Tris-HCl, 2 mM EDTA, pH 8.

0.

2. The preparation method of the nucleic acid extraction kit according to claim 1, characterized in that, It includes the following steps: (a) Obtain proteinase K; (b) Primary lysis buffer: Add the EDTA, the Tris-HCl, and the SDS to water, and dissolve and mix each component to obtain a mixture, and adjust the pH of the mixture; (c) Lysis-binding buffer: Add the guanidine hydrochloride, Tris-HCl, EDTA, Triton X-100, and Tween-20 to water, and dissolve and mix each component to obtain a mixture, and adjust the pH of the mixture; (d) Obtain magnetic bead suspension; (e) Obtain first wash buffer: Add the Tris-HCl, NaCl, and EDTA to water, and dissolve and mix each component to obtain a mixture, adjust the pH of the mixture, and add absolute ethanol to a final ethanol concentration of 70% before use; (f) Obtain second wash buffer: Add the Tris-HCl and EDTA to water, and dissolve and mix each component to obtain a mixture, adjust the pH of the mixture, and add absolute ethanol to a final ethanol concentration of 80% before use; (g) Obtain elution buffer: Add the Tris-HCl and EDTA to water, and dissolve and mix each component to obtain a mixture, and adjust the pH of the mixture; Among them, (a), (b), (c), (d), (e), (f), and (g) have no sequential order.

3. A method for nucleic acid extraction from a fecal sample, characterized in that, Using the nucleic acid extraction kit according to claim 1, it includes the following steps: (1) Add the primary lysis buffer to the fecal sample or fecal preservation solution sample for primary lysis treatment, separate to obtain the supernatant, and then add proteinase K and lysis-binding buffer to the supernatant, incubate to obtain sample A; (2) Add isopropanol and magnetic bead suspension to Sample A, incubate, place on a magnetic stand, and let stand until all magnetic beads are adsorbed. Discard all the liquid. (3) Rinse sequentially with the first wash solution and the second wash solution. (4) Elute the DNA bound to the magnetic beads with the elution buffer to obtain purified nucleic acid.

4. The nucleic acid extraction method according to claim 3, wherein The mass-to-volume ratio of the fecal sample or the fecal preservation solution sample to proteinase K is 5:1 - 20:

1.

5. The nucleic acid extraction method according to claim 3, wherein The addition amount of the primary lysis buffer is 200 - 800 μl for every 0.25 - 2 g of fecal sample or 200 - 400 μl of fecal preservation solution sample.

6. The nucleic acid extraction method according to any one of claims 3-5, characterized in that, The addition amount of the lysis-binding buffer is 200 - 400 μl for every 0.25 - 2 g of fecal sample or 200 - 400 μl of fecal preservation solution sample.

7. The nucleic acid extraction method according to any one of claims 3-5, characterized in that The temperature for the primary lysis treatment is 70 °C and the time is 3 - 5 min.

Citation Information

Patent Citations

  • Nucleic acid extraction lysate for cast-off cells in human feces and preparation method and application of nucleic acid extraction lysate

    CN107937391A

Cited By

  • Feces human DNA high-purity extraction method based on secondary magnetic bead purification

    CN122279002A